Humanetics selects lifecore biomedical to deliver cdmo services supporting development of bio 300 for the prevention of acute radiation syndrome

Humanetics' novel radioprotective agent being developed with funding from department of defense as radiation medical countermeasure (mcm)
CDMO Ratings Summary
CDMO Quant Ranking